← All organizations

Changchun BCHT Biotechnology Co.

For profitWebsite ↗

Also known as: Changchun BCHT Biotechnology Co.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

Last known activity

Jun 13, 2025

Timeline

2000s

Jun 1, 2004
Changchun BCHT Biotechnology Co.— Founded

Drugs by trial phase (12 distinct, 10 trials)

Phase 4 (2 own, 0 via acquisition)

Phase 3 (3 own, 0 via acquisition)

DTaP, inactivated poliovirus, haemophilus influenzae b conjugate, hepatitis b vaccine
Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine
acellular pertussis vaccine (including diptheria and tetanus toxoids)

Phase 2 (3 own, 0 via acquisition)

Phase 1 (4 own, 0 via acquisition)

Indications

Studied for

Recent trials (10)

NCT07112144Lead sponsorPhase 3Jun 13, 2025
NCT06961721Lead sponsorPhase 4May 31, 2025
NCT06548139Lead sponsorPhase 2Jul 31, 2024
NCT06360250Lead sponsorEarly Phase 1Apr 10, 2024
NCT06280144Lead sponsorPhase 4Sep 22, 2023
NCT05832073Lead sponsorEarly Phase 1Apr 30, 2023
NCT05284851Lead sponsorPhase 2Apr 1, 2022
NCT05056519Lead sponsorPhase 1Sep 20, 2021
NCT04334577Lead sponsorPhase 3Apr 30, 2020
NCT02964065Lead sponsorPhase 3Nov 1, 2016

Details

Founded: Changchun, CN Jun 1, 2004
Last known activity: Jun 13, 2025